Evidence map›Paper›PMID 32588989›Full record

ArticleAnnals of clinical and translational neurology2020

Demographic characteristics and neuropsychological assessments of subjective cognitive decline (SCD) (plus).

Lixiao Hao, Yu Sun, Yun Li, Jieyu Wang, Zichen Wang, Zhongying Zhang, Zhanyun Wei, Ge Gao, Jianguo Jia, Yue Xing and 1 more

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Gender differences in cognitive reserve: implication for subjective cognitive decline in women.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in neuroscience · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lixiao HaoDepartment of General Practice, XuanWu Hospital of Capital Medical University, Beijing, China.ORCID 0000-0003-4869-4251
Yu SunDepartment of Neurology, XuanWu Hospital of Capital Medical University, Beijing, China.
Yun LiDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Jieyu WangDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Zichen WangDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Zhongying ZhangDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Zhanyun WeiDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Ge GaoDepartment of Geriatrics, XuanWu Hospital of Capital Medical University, Beijing, China.
Jianguo JiaDepartment of General Surgery, XuanWu Hospital of Capital Medical University, Beijing, China.
Yue XingRadiological Sciences, Division of Clinical Neuroscience, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.
Ying HanDepartment of Neurology, XuanWu Hospital of Capital Medical University, Beijing, China.ORCID 0000-0003-0377-7424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince SCD (plus) was standardized, little is known about its demographic characteristics and its outcomes of neuropsychological assessments, including the SCD questionnaire 9 (SCD-Q9).

objectiveTo characterize SCD (plus) by comparing the neuropsychological features among its subgroups and with normal controls (NC). Also, to explore its demographics and to understand the relation of the chief complaints and the scores of SCD-Q9.

methodsMultistage stratified cluster random sampling was conducted to select participants. As a result, 84 NC and 517 SCD (plus) were included. SCD (plus) was further classified into several subgroups (SCD-C: concerned cognitive decline; SCD-F: complaints about SCD within the past five years; SCD-P: feeling performance being not as good as their peers; SCD+: presented> 3 of SCD (plus) features; SCD-: presented ≤ 3 of SCD (plus) features (see the diagnostic criteria for the details)) and between-group comparisons of neuropsychological scores were conducted. Point-biserial correlation and binary logistic regression analyses were performed to investigate the demographic characteristics of its subgroups. Finally, Spearman correlation was used to better understand the relation of SCD (plus) to SCD-Q9.

results(1) Scores of AVLT-LR (AVLT-LR: Auditory Verbal Learning Test-Long Delayed Recall) and MoCA-B (MoCA: Montreal Cognitive Assessment-Basic) were lower in the SCD-P group than those in the NC group, and the SCD+ group scored lower in the MoCA-B and CDT(CDT: Clock Drawing Test) than the SCD- group. (2) Females were more concerned than male participants. Individuals with lower education level felt that their cognitive performance were worse than their peers. Also, younger people might express concerns more than the more elderly. People who had complaints of SCD-P might be more likely to report SCD-C, but less likely to report SCD-F. (3) Positive correlations were found between the chief complaints of SCD (plus) and some items of SCD-Q9.

conclusionsSCD (plus) may be related to demographic factors. Individuals with SCD (plus) already exhibited cognitive impairment, which can be detected by SCD-Q9.

Indexed as

Neuropsychological TestsAgedAged, 80 and overAge FactorsAgingCognitive DysfunctionDiagnostic Self EvaluationFemaleHumansMaleMiddle AgedSex Factors

Identifiers

PMID32588989
PMCPMC7317645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.